BroadEye: An Ophthalmology Podcast

Amblyopia, Strabismus, and VR-based Visual Fields - Dr. Benjamin T. Backus From Vivid Vision

In this episode, Vivid Vision's Chief Science Officer Dr. Benjamin T. Backus explains how his company's technology has been used to treat Amblyopia and Strabismus using custom-built software integrated into portable VR headsets. Dr. Backus further highlights an unmet need for at-home visual field tests and how Vivid Vision is making this a reality. 

Low Vision and Technology; How eSight Is Bridging the Gap To Bring Sight To the Visually Imparied

In this episode, eSight user and coach Richard Weatherford and company CCO Brian McCollum provide an overview of eSight technology and how it can be life-changing for people with poor central vision due to degenerative retinal disease. The guests explore use cases for the technology, how the core offering has evolved over time, and how people living with low vision can connect with the company to demo the latest model.

The evolution and Future Of Accessibility At Google - Laura Allen

Laura Allen - Head of Strategy, Accessibility, and Disability Inclusion at Google - shares her journey from 10-year-old child with unexplained vision loss to a leader and force for change in the world of accessible technology. Laura further highlights some of the accessibility initiatives at Google that are close to heart as well as what she believes the future of accessibility will look like in the years ahead. 

Glaucoma: Causes, Risk Factors and Treatment Approaches - Dr. Hady Saheb

Dr. Hady Saheb, Assistant Professor of Ophthalmology and Director of Glaucoma Fellowship at McGill University, offers a detailed overview of Glaucoma. This informative discussion covers Glaucoma causes and risk factors, as well as a deep dive into the evolution of disease diagnosis and management.

Choroideremia, Ocular Genetics and the Importance of Great Mentors - Dr. Ian MacDonald

Dr. Ian MacDonald, Professor Emeritus in the Department of Ophthalmology at the University of Alberta, provides a detailed overview of the current state of genetic therapies for degenerative retinal diseases. Dr. MacDonald further describes Choroideremia, including disease pathology, prognosis, and potential treatment avenues. Finally, Dr. MacDonald explains his reaction to being nominated for a Lifetime Achievement Award by the Canadian College of Medical Geneticists, pointing out some of his own remarkable mentors throughout his career.

 

http://broadeye.org/ian/

Retinitis Pigmentosa - The Potential for Mutation-Independent Therapy - Dr. José-Alain Sahel

In this episode, we interview Dr. José-Alain Sahel, the chair and Distinguished Professor of the Department of Ophthalmology at the University of Pittsburgh School of Medicine, director of the UPMC Eye Center, and the Eye and Ear
Foundation Endowed Chair of Ophthalmology. Dr. Sahel provides an in-depth overview of optogenetics, including the current state of research and clinical trials. A detailed discussion about his team's recent publication in 
Nature Medicine highlights the potential sight-restoring impact that novel optogenetic therapies can have for patients with Retinitis Pigmentosa and potentially other degenerative retinal conditions.

 

http://broadeye.org/sahel/

Strabismus, Amblyopia and the Rise Of Telemedicine In Pediatric Ophthalmology - Dr. Sudha Nallasamy

Dr. Sudha Nallasamy, Assistant Professor at Keck School of Medicine of USC and Pediatric Ophthalmologist at the Children’s Hospital of Los Angeles, gives a detailed overview of strabismus, including why early diagnosis is critical. Dr. Nallasamy further describes her recent publication that highlights the reproducibility of clinical findings and management plans using telemedicine in a pediatric ophthalmology setting.

 

http://broadeye.org/nallasamy/

Rare Ophthalmic Diseases and the Ability to Collect, Manage and Share Patient Health Data - MyEyeSite

Dr. Andrew Webster, Lead of Genetics Service at Moorfields Eye Hospital and Chair of Molecular Ophthalmology at University College London, and Nick Nettleton, Founder and Chief Executive Officer at Loft Digital, provide a detailed overview of how MyEyeSite is changing the information landscape for rare ophthalmic diseases. The guests highlight how the MyEyeSite platform is bridging information gaps and enabling for better patient care while simultaneously creating a vast repository of information for researchers of rare ophthalmic diseases.

 

http://broadeye.org/myeyesite/

How Ophthalmology and General Medicine Intersect - Dr. Caitlin Reimer and Ophthalmologist Dr. Debra-Meghan Sanft

Guest interviewer Dr. Debra-Meghan Sanft interviews Dr. Caitlin Reimer to discuss the relationships, interactions, and overlap between an Ophthalmologist and a Family Doctor. They deep dive into Thyroid Disease, Diabetes, headaches, and how the eye can tell us what is going on in the rest of our body.

 

http://broadeye.org/caitlin/

Color Blindness and What Patients Can Do - Mark Mattison-Shupnick from Enchroma

Mark Mattison-Shupnick, master optician and COO at Enchroma, explains the different types of color deficiency, genetic or acquired, and its prevalence. Because colors are one of the first things we learn, kids with an undiagnosed condition can really struggle. We further discussed how special glasses with color filtering lenses can help them see colors again.

https://broadeye.org/enchroma